By: William Jones
In an age where the average American spends over seven hours daily staring at screens, a silent epidemic is unfolding before our very eyes. Computer Vision Syndrome (CVS), a constellation of eye and vision problems resulting from prolonged digital device use, now reportedly affects more than 70% of the population, making it one of the most widespread health concerns of the 21st century.
The symptoms are familiar to nearly everyone: eye strain, headaches, blurred vision, dry eyes, and neck and shoulder pain. Yet despite its prevalence, CVS remains largely unaddressed in mainstream healthcare, with millions experiencing these issues in silence as they navigate work, school, and leisure.
For pharmacist and father Devan Patel, the crisis became personal when he watched his two daughters struggle with the telltale signs of digital eye fatigue.
“Watching my girls squint at their devices and complain about tired eyes after homework sessions was heartbreaking,” Devan reflects. “As a pharmacist, I understood this wasn’t just about needing a break from screens; this was a legitimate physiological response to our modern lifestyle. I knew something had to be done.”
The CVS Epidemic: A Growing Crisis
The numbers present a concerning reality. Studies indicate that between 70-90% of people who use computers or digital devices for extended periods report some symptoms of Computer Vision Syndrome. For children and adolescents, whose screen time has increased in recent years, the implications are particularly concerning, with potential long-term effects on visual development still being studied.
The pandemic only accelerated this trend. Remote work, virtual schooling, and increased digital entertainment transformed our relationship with screens from significant to inescapable. What was once a concern primarily for office workers has become a common challenge affecting everyone from elementary students to retirees.
A Journey to Japan: Discovering EYEMUSE™
Devan’s search for solutions led him to groundbreaking research emerging from an unexpected source: Kirin Holdings, Ltd. in Japan. While globally recognized for its beverage empire, Kirin has quietly pioneered biotechnology research for decades, and its scientists have developed something remarkable, EYEMUSE™, a patented postbiotic specifically targeting digital eye fatigue.
Unlike traditional probiotics, which contain live bacteria, postbiotics use heat-killed bacterial strains that offer unique health benefits. EYEMUSE™ utilizes heat-killed Lacticaseibacillus paracasei KW3110, a strain that clinical research suggests could significantly reduce severe eye fatigue and discomfort associated with screen time.
“When I learned about EYEMUSE’s clinical research, I was fascinated by the mechanism,” Devan explains. “This postbiotic works by activating immune cells and stimulating IL-10 cytokine production, which helps maintain a balanced immunologic response and reduce digital stress-related eye fatigue. It was addressing CVS from a completely different angle than anything I’d seen before.”
The discovery was so compelling that Devan made an extraordinary decision: he flew to Japan to meet with the research team at their headquarters.
“Meeting the scientific team behind EYEMUSE™ and seeing their research facilities firsthand was incredible,” Devan shares. “The depth of their clinical studies and the rigor of their approach led me to believe this could be truly innovative science.”
A Collaborative Approach to a Modern Problem
Recognizing that addressing Computer Vision Syndrome required comprehensive expertise, Devan partnered with Doctor of Optometry Dr. Sangita Vadapalli to develop a solution that combined cutting-edge science with practical application.
The Eye-Mazen Gummy™ is the first eye health gummy developed to incorporate EYEMUSE’s postbiotic technology, containing also a Patented Cognzin, which was shown in clinical studies to help with attention, focus, and concentration. The product specifically targets the needs of kids, gamers, and business professionals who spend more than six hours daily on computers or digital devices, precisely the populations most affected by CVS.
Clinical studies of the EYEMUSE™ ingredient showed encouraging results, with participants experiencing reduced eye fatigue symptoms, including ocular discomfort and muscle stiffness, the hallmark complaints of Computer Vision Syndrome sufferers.
From Father to Innovator
For Devan, the journey from concerned parent to pioneer in eye health innovation reflects values instilled by his own upbringing.
“My parents taught me early on about hard work, integrity, and truly caring about others’ well-being,” Devan says. “Becoming a father has only deepened my understanding of that responsibility. When I see my daughters taking their daily Eye-Mazen Gummy™ without any fuss, knowing it’s supporting their eye health as they navigate school and homework, that’s when the science truly comes to life.”
As Computer Vision Syndrome continues to affect an ever-growing portion of the population, innovative approaches like postbiotic technology could represent a new frontier in addressing one of modern life’s most pervasive health challenges.
With over 70% of Americans now experiencing CVS symptoms, the question is no longer whether digital eye fatigue is a real problem, but rather, how quickly can science and innovation rise to meet this modern epidemic.
Disclaimer: The information provided in this article is for informational purposes only and is not intended as medical advice. The claims made about the effectiveness of products or treatments have not been evaluated by the Federal Trade Commission (FTC) or other regulatory bodies. Individual results may vary. Always consult with a healthcare professional before making any changes to your health regimen or if you have any concerns regarding your eye health or vision.
